Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-23

FDA Approved: REGADENOSON — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved Regadenoson (REGADENOSON) as a pharmacologic stress agent for myocardial perfusion imaging in adults unable to perform exercise testing, marking Ba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Regadenoson (Regadenoson)

Snippet

ORIG AP for REGADENOSON (REGADENOSON)